Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Brittany C Waschke"'
Autor:
Antonio Jimeno, Rachel A Woolaver, Xiaoguang Wang, Alexandra L Krinsky, Brittany C Waschke, Samantha M Y Chen, Vince Popolizio, Andrew G Nicklawsky, Dexiang Gao, Zhangguo Chen, Xiao-Jing Wang, Jing Hong Wang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)
Background Antitumor immunity is highly heterogeneous between individuals; however, underlying mechanisms remain elusive, despite their potential to improve personalized cancer immunotherapy. Head and neck squamous cell carcinomas (HNSCCs) vary signi
Externí odkaz:
https://doaj.org/article/26f856b3ea3f4c039114e8c84bba4f37
Autor:
Jing Wang, Zhangguo Chen, Xiaoguang Wang, Rachel A. Woolaver, Samantha M. Y. Chen, Brittany C. Waschke
Publikováno v:
Cell Mol Immunol
Cancer cells can evade immune recognition by losing major histocompatibility complex (MHC) class I. Hence, MHC class I-negative cancers represent the most challenging cancers to treat. Chemotherapeutic drugs not only directly kill tumors but also mod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81fc7fa004c2a23cdb23e4b34549fcc2
https://doi.org/10.1038/s41423-020-0463-2
https://doi.org/10.1038/s41423-020-0463-2
Autor:
Brittany C. Waschke, Jing Wang, Zhangguo Chen, Samantha M. Y. Chen, Xiaoguang Wang, Rachel A. Woolaver
Publikováno v:
Protein & Cell
Protein & Cell, Vol 11, Iss 7, Pp 472-482 (2020)
Protein & Cell, Vol 11, Iss 7, Pp 472-482 (2020)
Immunotherapy has been applied successfully to treat B-cell lymphomas in preclinical models or clinical settings. However, immunotherapy resistance is a major challenge for B-cell lymphoma treatment. To overcome this issue, combinatorial therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba809ee008eb49f95a383a8fb7db2064
http://europepmc.org/articles/PMC7305292
http://europepmc.org/articles/PMC7305292
Autor:
Brittany C. Waschke, Rachel A. Woolaver, Jing Wang, Anthony D. Piscopio, Xuedong Liu, Gan Zhang, Xiaoguang Wang, Zhangguo Chen
Publikováno v:
Cancer Immunology Research. 7:1318-1331
PD1 blockade is effective in a subset of patients with B-cell lymphoma (e.g., classical-Hodgkin lymphomas); however, most patients do not respond to anti-PD1 therapy. To study PD1 resistance, we used an isoform-selective histone deacetylase inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07246219ed47d3bb94a2fd68183e0344
https://doi.org/10.1158/2326-6066.cir-18-0875
https://doi.org/10.1158/2326-6066.cir-18-0875
Autor:
Andrew Nicklawsky, Xiao-Jing Wang, Rachel A. Woolaver, Jing Hong Wang, Zhangguo Chen, Xiaoguang Wang, Samantha M. Y. Chen, Dexiang Gao, Antonio Jimeno, Vince Popolizio, Alexandra L Krinsky, Brittany C. Waschke
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundAntitumor immunity is highly heterogeneous between individuals; however, underlying mechanisms remain elusive, despite their potential to improve personalized cancer immunotherapy. Head and neck squamous cell carcinomas (HNSCCs) vary signif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82e4c17a26a06d959077505bcafd07db
https://doi.org/10.1136/jitc-2020-001615
https://doi.org/10.1136/jitc-2020-001615
Autor:
Zhangguo Chen, Xuedong Liu, Xiaoguang Wang, Anthony D. Piscopio, Gan Zhang, Rachel A. Woolaver, Jing Wang, Brittany C. Waschke
Publikováno v:
Blood Cancer Discovery. 1:PO-54
PD1 blockade is effective in a subset of B-cell lymphoma patients (e.g., classical Hodgkin lymphomas); however, most patients do not respond to anti-PD1 therapy. To overcome PD1 resistance, we employ a newly developed isoform-selective histone-deacet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2329f1ee4caecaab9b29cf22ae27357
https://doi.org/10.1158/2643-3249.lymphoma20-po-54
https://doi.org/10.1158/2643-3249.lymphoma20-po-54
Autor:
Xiaoguang Wang, Brittany C. Waschke, Rachel A Woolaver, Samantha M. Y. Chen, Zhangguo Chen, Jing H. Wang
Publikováno v:
Protein & Cell, Vol 11, Iss 7, Pp 472-482 (2020)
Abstract Immunotherapy has been applied successfully to treat B-cell lymphomas in preclinical models or clinical settings. However, immunotherapy resistance is a major challenge for B-cell lymphoma treatment. To overcome this issue, combinatorial the
Externí odkaz:
https://doaj.org/article/d9e84d707dd3487cac150e395a2a17fd